Bitte wählen Sie:

Universitätsklinikum Essen
Direkteinstieg:
Forschung

Univ.-Prof. Dr. phil. nat. Katharina Lückerath

Professor Preclinical Theranostics

Katharina is a biomedical scientist with a focus on experimental and translational theranostics. She is interested in understanding mechanisms underlying failure of radioligand therapy, and aims at improving theranostic approaches and thus, outcomes for cancer patients. Katharina obtained her PhD at the Institute for Tumor Biology and Experimental Therapy (Georg-Speyer-Haus, Germany). She served as head of the research group Experimental Oncology in Nuclear Medicine at the University of Würzburg (Germany), and of the pre-clinical Nuclear Medicine team at the University of California Los Angeles (USA), before transferring to University Hospital Essen in March 2021.

E-Mail

Dr. Magdalena Staniszewska

Postdoc

Magdalena obtained her M.Sc. from the Institute of Pathology, University Duisburg-Essen. In 2018, she joined our group as a doctoral researcher and member of the GRK 1739 training program in radiation sciences. In her PhD project she focused on establishing radioligand - drug combination therapies for advanced prostate cancer and continues this work as postoc.

 

 

E-Mail

Dr. Verena Behnke

Postdoc

Verena is a biologist with a focus on immunology. She obtained her PhD studying microglial immunology of the eye at the University of Cologne. Since 2022 she is part of our team and focuses on modulation of the tumor microenvironment by radioligands in pancreatic cancer.

 

 

 

E-Mail

Lara Breuer

Graduate student

Lara received her M. Sc. in Molecular Cell Biology from the University of Bielefeld focusing on the cytotoxicity of natural killer cells. She joined our group in 2022 as a doctoral researcher and is a member of the GRK 2762 training program, which aims at elucidating the biological principles underlying the radiosensitivity / radioresistance. She focuses on exploring a new radioimmunotherapy to target pancreatic ductal adenocarcinoma.

 

 

E-Mail

Jasmin Wosniack

State-certified biological technical assistant

Jasmin completed her training as a biological technical assistant in Düsseldorf in 2017. Since 2018 she works in our preclinical research group. Currently she focuses on preclinical imaging and translational oncology. In addition, she coordinates and performs PET/CT imaging for cooperation projects with internal and external research groups.

E-Mail

Jessica Pletz

State-certified biological technical assistant

Jessica completed her training as a biological technical assistant at the DZNE in Bonn in 2020. Since summer 2020 she works at the University of Essen and in 2022 joined our preclinical research Group.

 

 

E-Mail

 

 

Experimental Radiochemistry

Dr. Valeska von Kiedrowski

Postdoc

Valeska obtained her PhD from the University of Dortmund for the total synthesis and structural elucidation of complex natural products in the field of organic chemistry. During her PostDocs her research focus was expanded by the design, bioconjugation, radiolabelling and in vitro/in vivo evaluation of new radiotracers. She joined our team in 2021 and is currently working on automating the radiolabeling of liposomes. Valeska enjoys to learn from future collaborative projects.

E-Mail

Dr. Anna Pacelli

Postdoc

Anna is a medicinal chemist/radiochemist with postdoctoral experience in organic synthesis, fluorine-18 and carbon-11 radiolabelling, and automation. Her research focuses on the development of novel PET tracers and the optimisation of radiosynthesis and quality control for clinical applications.

E-Mail

 

 

Nuclear-Cardiology

Dr. Zohreh Varasteh

Postdoc

Zohreh is a radionuclide-imaging scientist with a focus on experimental nuclear cardiology. She is interested in using nuclear imaging approaches to assess the efficacy of novel therapeutics for cardiac diseases to identify optimal therapeutic approaches to improve outcomes. Zohreh obtained her PhD at Uppsala University (Uppsala, Sweden). She worked as a research fellow at Klinikum rechts der Isar der TUM (Munich, Germany), before joining the team of preclinical nuclear medicine University Hospital Essen in March 2022.

E-Mail